These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11825062

  • 1. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
    Al-Dhalimy M, Overturf K, Finegold M, Grompe M.
    Mol Genet Metab; 2002 Jan; 75(1):38-45. PubMed ID: 11825062
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
    Orejuela D, Jorquera R, Bergeron A, Finegold MJ, Tanguay RM.
    J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
    Lock EA, Gaskin P, Ellis MK, Robinson M, Provan WM, Smith LL.
    Toxicol Appl Pharmacol; 1998 May; 150(1):125-32. PubMed ID: 9630461
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hereditary Tyrosinemia Type 1 in Turkey.
    Aktuglu-Zeybek AC, Kiykim E, Cansever MS.
    Adv Exp Med Biol; 2017 May; 959():157-172. PubMed ID: 28755194
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat.
    Lock EA, Gaskin P, Ellis MK, Provan WM, Robinson M, Smith LL, Prisbylla MP, Mutter LC.
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):439-47. PubMed ID: 8975769
    [Abstract] [Full Text] [Related]

  • 14. Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation.
    Colemonts-Vroninks H, Neuckermans J, Marcelis L, Claes P, Branson S, Casimir G, Goyens P, Martens GA, Vanhaecke T, De Kock J.
    Genes (Basel); 2020 Dec 22; 12(1):. PubMed ID: 33375092
    [Abstract] [Full Text] [Related]

  • 15. Nitisinone: new drug. Type 1 tyrosinemia: an effective drug.
    Prescrire Int; 2007 Apr 22; 16(88):56-8. PubMed ID: 17458044
    [Abstract] [Full Text] [Related]

  • 16. Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome.
    Nobili V, Jenkner A, Francalanci P, Castellano A, Holme E, Callea F, Dionisi-Vici C.
    Pediatrics; 2010 Jul 22; 126(1):e235-8. PubMed ID: 20547648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
    Eggenhofer E, Doenecke A, Renner P, Slowik P, Piso P, Geissler EK, Schlitt HJ, Dahlke MH, Popp FC.
    J Gastroenterol Hepatol; 2010 May 22; 25(5):1002-8. PubMed ID: 20546455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.